Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Cell
|
February 25, 2006
The evolution of adaptive immune systems
Max D Cooper, Matthew N Alder
Pediatric Emergency Care
|
November 10, 2011
A "rare" case of melena in a 3-year-old
Matthew N Alder, Nathan L Timm
Critical Care (London, England)
|
October 1, 2018
The glucocorticoid receptor and cortisol levels in pediatric septic shock
Matthew N Alder, Amy M Opoka, Hector R Wong
Expert Review of Anti-Infective Therapy
|
April 24, 2014
The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology
Matthew N Alder, Christopher J Lindsell, Hector R Wong
Neonatology
|
December 22, 2022
Olfactomedin-4-Positive Neutrophils in Neonates: Link to Systemic Inflammation and Bronchopulmonary Dysplasia
Faris N Al Gharaibeh, Kristalynn M Kempton, Matthew N Alder
RNA (New York, N.Y.)
|
January 30, 2003
Gene silencing in Caenorhabditis elegans by transitive RNA interference
Matthew N Alder, Shale Dames, Jeffrey Gaudet, et al.
Pediatric Research
|
December 13, 2022
Biomarkers estimating baseline mortality risk for neonatal sepsis: nPERSEVERE: neonate-specific sepsis biomarker risk model
Faris N Al Gharaibeh, Patrick Lahni, Matthew N Alder, et al.
Shock (Augusta, Ga.)
|
January 4, 2023
OBESE MICE WITH PNEUMONIA HAVE HYPERLEPTINEMIA AND INCREASED PULMONARY SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 ACTIVATION
Lauren Bodilly, Lauren Williamson, Kendra Howell, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 11, 2025
Olfactomedin-4 Elevation in Pediatric Acute Respiratory Distress Syndrome
Ryan O'Sullivan, Matthew N Alder, Celeste G Dixon, et al.
Critical Care Medicine
|
September 17, 2016
Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock
Matthew N Alder, Amy M Opoka, Patrick Lahni, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Cell
|
February 25, 2006
The evolution of adaptive immune systems
Max D Cooper, Matthew N Alder
Pediatric Emergency Care
|
November 10, 2011
A "rare" case of melena in a 3-year-old
Matthew N Alder, Nathan L Timm
Critical Care (London, England)
|
October 1, 2018
The glucocorticoid receptor and cortisol levels in pediatric septic shock
Matthew N Alder, Amy M Opoka, Hector R Wong
Expert Review of Anti-Infective Therapy
|
April 24, 2014
The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology
Matthew N Alder, Christopher J Lindsell, Hector R Wong
Neonatology
|
December 22, 2022
Olfactomedin-4-Positive Neutrophils in Neonates: Link to Systemic Inflammation and Bronchopulmonary Dysplasia
Faris N Al Gharaibeh, Kristalynn M Kempton, Matthew N Alder
RNA (New York, N.Y.)
|
January 30, 2003
Gene silencing in Caenorhabditis elegans by transitive RNA interference
Matthew N Alder, Shale Dames, Jeffrey Gaudet, et al.
Pediatric Research
|
December 13, 2022
Biomarkers estimating baseline mortality risk for neonatal sepsis: nPERSEVERE: neonate-specific sepsis biomarker risk model
Faris N Al Gharaibeh, Patrick Lahni, Matthew N Alder, et al.
Shock (Augusta, Ga.)
|
January 4, 2023
OBESE MICE WITH PNEUMONIA HAVE HYPERLEPTINEMIA AND INCREASED PULMONARY SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 ACTIVATION
Lauren Bodilly, Lauren Williamson, Kendra Howell, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
June 11, 2025
Olfactomedin-4 Elevation in Pediatric Acute Respiratory Distress Syndrome
Ryan O'Sullivan, Matthew N Alder, Celeste G Dixon, et al.
Critical Care Medicine
|
September 17, 2016
Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock
Matthew N Alder, Amy M Opoka, Patrick Lahni, et al.
Page
of 4